The Newsroom
Deals·October 13, 2026 at 6:20 AM EDT·1 source

J&J Leans Toward Ortho Spinoff as Medtech Sales Disappoint

JNJ -1.4%
JNJ · last 30 trading days+0.0% since the news
News

What happened

  • Johnson & Johnson reported another quarter of weak sales in its medical technology division.
  • The company said it is leaning toward spinning off, rather than selling, its orthopedics business.

Why it matters

The potential separation could affect Johnson & Johnson’s portfolio strategy and create a significant healthcare corporate-finance transaction.

What to watch. Whether Johnson & Johnson formally announces a spinoff or pursues a sale of the orthopedics business.

Deal terms

spin off
Johnson & Johnson orthopedics business
Value
—
Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

Sources (1)

  1. BloombergOct 13
    J&J Leans Toward Ortho Spinoff as Medtech Sales Disappoint

Related

Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

  • Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
  • Follow developing storiesAn alert, and a push, the moment a story you follow moves.
  • Your briefing, read aloudA few minutes each morning with a chapter per story.
  • Brief modeSwipe through the day, a 20-second card each.